Position in LLY
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$959,544
+$223,728 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3,180
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CACTI ASSET MANAGEMENT LLC holds $154,335,418 across 7 Drug Manufacturers - General names. LLY ranks #5 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
645,299 | $82,920,921 | |
| 2 | JNJ |
Johnson & Johnson
|
258,168 | $65,566,926 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
36,450 | $2,100,249 | |
| 4 | PFE |
Pfizer Inc
|
69,850 | $1,681,988 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
800 | $959,544 | |
| 6 | NVO |
Novo Nordisk A S
|
16,000 | $767,040 | |
| 7 | OGN |
Organon & Co.
|
25,000 | $338,750 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $959,544 | 800 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $735,816 | 800 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $859,744 | 800 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $610,400 | 800 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $623,624 | 800 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $660,728 | 800 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $617,600 | 800 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $885,940 | 1,000 | Shares | Sole | 2024-10-02 | |
| 2024-06-30 | $905,380 | 1,000 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $777,960 | 1,000 | Shares | Sole | 2024-06-03 | |
| 2023-12-31 | $582,920 | 1,000 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $537,130 | 1,000 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $468,980 | 1,000 | Shares | Sole | 2023-07-03 | |
| 2023-03-31 | $343,420 | 1,000 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $365,840 | 1,000 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $323,350 | 1,000 | Shares | Sole | 2022-10-03 | |
| 2022-06-30 | $324,230 | 1,000 | Shares | Sole | 2022-07-01 | |
| 2022-03-31 | $286,370 | 1,000 | Shares | Sole | 2022-04-01 | |
| 2021-12-31 | $6,803,298 | 24,630 | Shares | Sole | 2022-01-03 | |
| 2021-09-30 | $231,050 | 1,000 | Shares | Sole | 2021-10-01 | |
| 2021-06-30 | $229,520 | 1,000 | Shares | Sole | 2021-07-01 | |
| 2021-03-31 | $186,820 | 1,000 | Shares | Sole | 2021-04-01 | |
| 2020-12-31 | $168,840 | 1,000 | Shares | Sole | 2021-01-04 | |
| 2020-09-30 | $148,020 | 1,000 | Shares | Sole | 2020-10-01 | |
| 2020-06-30 | $164,180 | 1,000 | Shares | Sole | 2020-07-02 | |
| 2020-03-31 | $138,720 | 1,000 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||